Nasdaq
CADL
Candel Therapeutics, Inc.
- Health Care
- Listed 2021
- 1 day
- +1.1%
- 1 month
- +7.4%
- 1 year
- +77.5%
$10.58 · Mkt cap $775M
At the 6 Aug 2026 close
Nasdaq
Candel Therapeutics, Inc.
$10.58 · Mkt cap $775M
At the 6 Aug 2026 close
Candel Therapeutics, Inc. trades under the ticker CADL on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2021. Its market capitalisation is $775M. The last closing price was $10.58, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +77.5%, and +7.4% over the past month. Returns are price returns and exclude dividends.
This page exists because CADL is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.